<- Go Home

Heska Corporation

Heska Corporation manufactures and sells diagnostic and specialty products and solutions for veterinary practitioners in the United States, Canada, Mexico, Germany, Italy, Spain, France, Switzerland, Australia, and Malaysia. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell, platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was incorporated in 1988 and is based in Loveland, Colorado. As of December 29, 2023, Heska Corporation operates as a subsidiary of Veterinary Pharmaceutical Solutions.

Market Cap

$1.3B

Volume

102.1K

Cash and Equivalents

$125.2M

EBITDA

-$9.3M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$109.4M

Profit Margin

42.93%

52 Week High

$120.03

52 Week Low

$57.83

Dividend

N/A

Price / Book Value

3.14

Price / Earnings

-62.14

Price / Tangible Book Value

6.34

Enterprise Value

$1.3B

Enterprise Value / EBITDA

-171.83

Operating Income

-$24.0M

Return on Equity

4.73%

Return on Assets

-2.51

Cash and Short Term Investments

$125.2M

Debt

$109.9M

Equity

$417.7M

Revenue

$254.9M

Unlevered FCF

-$3.2M

Sector

Health Care Equipment and Supplies

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches